CA IX shedding was increased in cells undergoing apoptosis from cytotoxic agents such as doxorubicin, suggesting that soluble levels could be used as a biomarker for the effectiveness of cancer-therapeutic agents [90]. The gene discussed is CA9; the disease is cancer.